Cefiderocol study in burn injury patients
Treatments studied
Part of Infections, Injuries & trauma clinical trials.
This trial tests how the antibiotic cefiderocol works in burn patients. It aims to ensure the drug is safe and effective for treating infections in people with severe burns.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old
- Your kidney function is normal or near normal (estimated clearance of 60 mL/min or higher)
- You do not have acute kidney injury at the start of the study
- You do not have HIV or hepatitis B infection
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well a new antibiotic (cefiderocol) works against a tough type of Klebsiella pneumoniae bacteria that is resistant to many other antibiotics. It may help find better treatments for serious infections.
This study collects tissue and blood samples from burn patients to improve a computer model that predicts sepsis (a severe infection). The goal is to help doctors identify and treat sepsis earlier in burn patients.
This trial tests a special blood filter called Efferon LPS that removes harmful substances from the blood of people with severe burns. It aims to help the body recover by reducing inflammation and infection.
This Phase 3 study tests whether giving preventive antibiotics lowers infection risk when you need surgery to remove burned skin and place a skin graft. It may help patients heal with fewer serious infections, but it also depends on your antibiotic allergy and current health status.
This trial compares three treatments for a severe diarrhea infection called C. diff: a fecal transplant (putting healthy donor stool into your gut), a newer antibiotic called fidaxomicin, and an older antibiotic called vancomycin. The goal is to see which works best and prevents the infection from coming back.
This trial tests whether giving healthy bacteria through capsules (a fecal transplant) can help get rid of CRE, a type of bacteria that is hard to treat because it resists many antibiotics. If successful, this could reduce the risk of serious infections.
Hear when a new Drug Clearance After Severe Burn Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.